MENARINI Group
Company Details
Linkedin ID:
menarini
Website:
Employees number:
10,572
Number of followers:
411,621
NAICS:
3254
Industry Type:
Homepage:
menarini.com
IP Addresses:
0
Company ID:
MEN_4473648
Scan Status:
In-progress
MENARINI Group Company CyberSecurity Posture
menarini.com
The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group
MENARINI Group A.I CyberSecurity Scoring
MENARINI Group Risk Score (AI oriented)Between 750 and 799
MENARINI Group
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
MENARINI Group Global Score (TPRM)XXXX
MENARINI Group
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
MENARINI Group Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
MENARINI Group Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for MENARINI Group
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for MENARINI Group in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for MENARINI Group in 2025.
Incident Types MENARINI Group vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for MENARINI Group in 2025.
Incident History — MENARINI Group (X = Date, Y = Severity)
MENARINI Group cyber incidents detection timeline including parent company and subsidiaries
MENARINI Group Company Subsidiaries
The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group
Loading...
MENARINI Group Similar Companies
Dr. Reddy's Laboratories
Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics
AUROBINDO PHARMA LTD
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active
Alembic Pharmaceuticals Limited
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol
Hyderabad Pharmaceutical Congress Committee
HPCC- Hyderabad pharmaceutical congress committee is an apex body representing Indian pharmacists working in various capacities, viz,pharmaceutical industry,research and development,quality control,quality assurance,academics,drug control departments,hospitals,community and clinical pharmacy,marketi
Cipla
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purp
Parexel
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more th
Alkem Laboratories Ltd.
A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient,
Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage
Astellas Pharma
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneer
.png)
MENARINI Group CyberSecurity News
November 24, 2025 03:20 PM
Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics,...
January 13, 2025 08:00 AM
Menarini, Insilico Medicine deepen AI partnership with potential $550M deal
Drug discovery startup Insilico Medicine and Italian pharmaceutical company Menarini Group announced their second licensing agreement.
January 10, 2025 08:00 AM
Menarini and Insilico ink $550M deal for AI-discovered cancer therapy
Menarini Group and Insilico Medicine deepen their AI-driven oncology partnership with a second licensing deal.
January 10, 2025 08:00 AM
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics,...
May 07, 2024 07:00 AM
Eurotech introduces AI game-changers: ReliaCOR 31-11 & 33-11 powered by NVIDIA Jetson Orin
Raising the bar in AI integration by reducing complexity and technical barriers for organisations implementing AI solutions.
May 05, 2020 07:00 AM
Menarini Group to buy Stemline Therapeutics in deal valued at $677m
Italian pharmaceutical and diagnostics company Menarini Group has signed a definitive agreement to acquire US-based Stemline Therapeutics...
July 24, 2014 07:00 AM
Menarini Group Heirs Set To Inherit $10.4B, But The Tax Man Is After Them
Massimiliana Landini Aleotti and her three children, currently running Menarini, Italy's leading pharma company, are set to inherit an estimated fortune of $10...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
MENARINI Group CyberSecurity History Information
Official Website of MENARINI Group
The official website of MENARINI Group is https://www.menarini.com.
MENARINI Group’s AI-Generated Cybersecurity Score
According to Rankiteo, MENARINI Group’s AI-generated cybersecurity score is 782, reflecting their Fair security posture.
How many security badges does MENARINI Group’ have ?
According to Rankiteo, MENARINI Group currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does MENARINI Group have SOC 2 Type 1 certification ?
According to Rankiteo, MENARINI Group is not certified under SOC 2 Type 1.
Does MENARINI Group have SOC 2 Type 2 certification ?
According to Rankiteo, MENARINI Group does not hold a SOC 2 Type 2 certification.
Does MENARINI Group comply with GDPR ?
According to Rankiteo, MENARINI Group is not listed as GDPR compliant.
Does MENARINI Group have PCI DSS certification ?
According to Rankiteo, MENARINI Group does not currently maintain PCI DSS compliance.
Does MENARINI Group comply with HIPAA ?
According to Rankiteo, MENARINI Group is not compliant with HIPAA regulations.
Does MENARINI Group have ISO 27001 certification ?
According to Rankiteo,MENARINI Group is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of MENARINI Group
MENARINI Group operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at MENARINI Group
MENARINI Group employs approximately 10,572 people worldwide.
Subsidiaries Owned by MENARINI Group
MENARINI Group presently has no subsidiaries across any sectors.
MENARINI Group’s LinkedIn Followers
MENARINI Group’s official LinkedIn profile has approximately 411,621 followers.
NAICS Classification of MENARINI Group
MENARINI Group is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
MENARINI Group’s Presence on Crunchbase
No, MENARINI Group does not have a profile on Crunchbase.
MENARINI Group’s Presence on LinkedIn
Yes, MENARINI Group maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/menarini.
Cybersecurity Incidents Involving MENARINI Group
As of December 14, 2025, Rankiteo reports that MENARINI Group has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
MENARINI Group has an estimated 5,432 peer or competitor companies worldwide.
MENARINI Group CyberSecurity History Information
How many cyber incidents has MENARINI Group faced ?
Total Incidents: According to Rankiteo, MENARINI Group has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at MENARINI Group ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
A weakness has been identified in itsourcecode Online Pet Shop Management System 1.0. This vulnerability affects unknown code of the file /pet1/addcnp.php. This manipulation of the argument cnpname causes sql injection. The attack can be initiated remotely. The exploit has been made available to the public and could be exploited.
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
A security flaw has been discovered in Tenda AX9 22.03.01.46. This affects the function image_check of the component httpd. The manipulation results in use of weak hash. It is possible to launch the attack remotely. A high complexity level is associated with this attack. It is indicated that the exploitability is difficult. The exploit has been released to the public and may be exploited.
Risk Information
cvss2
Base: 2.6
Severity: HIGH
AV:N/AC:H/Au:N/C:N/I:P/A:N
cvss3
Base: 3.7
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
A weakness has been identified in code-projects Student File Management System 1.0. This issue affects some unknown processing of the file /admin/update_student.php. This manipulation of the argument stud_id causes sql injection. The attack is possible to be carried out remotely. The exploit has been made available to the public and could be exploited.
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
A security flaw has been discovered in code-projects Student File Management System 1.0. This vulnerability affects unknown code of the file /admin/save_user.php. The manipulation of the argument firstname results in sql injection. The attack can be executed remotely. The exploit has been released to the public and may be exploited.
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
A vulnerability was identified in code-projects Student File Management System 1.0. This affects an unknown part of the file /admin/update_user.php. The manipulation of the argument user_id leads to sql injection. Remote exploitation of the attack is possible. The exploit is publicly available and might be used.
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=menarini' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
